Im a bit behind on this, they actually came out about a month ago but some numbers and pretty pictures.
The story is pretty much the same as 2012
(Last Years Analysis) testing is up, but actually analysis is still very low in relation to the number of samples collected, and there are still areas of concern.
The full set of reports are
Here (zipped PDF's)Some summaries:
Total Samples Analysed & Reported by ADAMS (Not Including Bio Passport) | IC Urine | OC Urine | IC Blood | OC Blood |
---|
2013 | 13947 | 7081 | 543 | 667 |
2012 | 12521 | 6797 | 643 | 663 |
Percentage of Urine Samples Collected – tested for EPO – 2012/2013Once again, this one is a concern. Like 2012, plenty of samples are collected, but the number actually analysed for EPO remains very low.
Year | Total IC Samples | IC Analysed | IC % Analysed | Total OC Samples | OC Analysed | OC % Analysed | Total % Analysed |
---|
2013 | 13943 | 3991 | 28.62 | 7081 | 3331 | 47.04 | 34.83 |
2012 | 12521 | 3085 | 24.64 | 6797 | 4538 | 66.76 | 39.46 |

One of my big arguments last year was that they analysed a much bigger percentage of OOC samples for EPO, despite the much lower rate of success (success being positive tests), as considering halflife/glowtime youve got to be pretty retarded to test positive for EPO out of competition. It is noticable that the percentage of samples analysed OOC has dropped, and the percentage of IC samples analysed has increased (whilst the overall number of samples analysed has remained pretty static).
So thats a good thing, but I still think much greater emphasis on testing needs to be IN competition especially when you consider the positive rate IC is considerably higher.
Talking of the rate of positive...
Percentage of Urine Samples testing positive for EPO (Based on number of AAF v Analysed Samples) | IC Collected | IC Analysed | IC AAF's | IC AAF% | OC Collected | OC Analysed | OC AAF | OC AAF% | Total AAF |
---|
2013 | 13943 | 3991 | 23 | 0.58 | 7081 | 3331 | 6 | 0.18 | 0.40 |
2012 | 12521 | 3085 | 22 | 0.71 | 6797 | 4538 | 5 | 0.11 | 0.35 |

As with 2012, the rate of positive from In Competition samples is considerably higher than the rate of positive in Out of Competition samples. The %'s change a little this year, but that is possibly explained by the higher number of IC samples being analysed, and the lower number of OC samples being tested. But i remain convinced that the focus and resources of analysing samples for EPO needs to be the IC samples collected.
GC/C/IRMS Tests (Gas Chromatograph/Carbon/Isotope Ratio Mass Spectrometer)) | In Competition | AAF | Out of Competition | AAF | Total AAF % |
---|
2013 | 566 | 22 | 294 | 3 | 2.91 |
2012 | 377 | 23 | 166 | 4 | 4.97 |
hGH Blood Tests Conducted | In Competition | AAF | Out of Competition | AAF | Total AAF % |
---|
2013 | 117 | 0 | 394 | 0 | 0.00 |
2012 | 180 | 0 | 393 | 1 | 0.17 |
HBT Blood Tests Conducted | In Competition | AAF | Out of Competition | AAF | Total AAF % |
---|
2013 | 102 | 0 | 55 | 0 | 0.00 |
2012 | 213 | 0 | 71 | 0 | 0.00 |
HBOCS Blood tests Conducted | In Competition | AAF | Out of Competition | AAF | Total AAF % |
---|
2013 | 25 | 0 | 59 | 0 | 0.00 |
2012 | 118 | 0 | 72 | 0 | 0.00 |
Biological Passport Samples Collected | In Competition | Out of Competition | Total |
---|
2012 | 2072 | 4352 | 6424 |
2013 | 2632 | 4797 | 7429 |
